Phase 1 APOLLO data update demonstrated encouraging clinical activity with a 66% objective response rate in relapsed non-Hodgkin lymphoma, including 50% complete responses Research published in Nature ...

Incyte (NASDAQ:INCY) executives outlined the company’s near-term launch priorities and mid-stage pipeline plans during a presentation at the Barclays conference, emphasizing a strategy to sustain ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...

An innovative care delivery model at Mayo Clinic integrates virtual oversight, remote patient monitoring, mobile health ...

OhioHealth breaks ground 226M cancer center in Columbus to centralize outpatient oncology services with completion expected in late 2028.

Today, our scientists and doctors are transforming cancer care through precision immuno-oncology — tailoring immunotherapy treatments to the unique biology of each patient's cancer. At MSK, ...

Pfizer and Bristol Myers are racing to strengthen oncology portfolios through deals, new drugs and pipelines ??? investors ...

As it is, Ren is one of the newest members at the Renaissance School of Medicine at Stony Brook University. An Assistant Professor in the division of Hematology/ Oncology, Ren joined the downstate ...

Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of 2026 Phase 1 study of PRT12396 in patients with ...

For the fourth quarter of 2024, GAAP diluted loss per ADS includes $0.04 loss per ADS attributable to the dilutive ADS outstanding for purposes of this reconciliation. As the Company was in a GAAP net ...

Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.

In case you've faced some hurdles solving the clue, Basics, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...